Pharmacy Board of Australia v Naghdi

Link copied
Case Copied 15 min read
CITATION: Pharmacy Board of Australia v Naghdi [2012] QCAT 675
PARTIES: Pharmacy Board of Australia
(Applicant)
v
Sara Naghdi
(Respondent)
APPLICATION NUMBER: OCR279-11
MATTER TYPE: Occupational regulation matters
HEARING DATE: 19 September and 28 November 2012
HEARD AT: Brisbane
DECISION OF: Kerrie O’Callaghan, A/Deputy President
Assisted by:
Bronwyn Herbertson
Warren Blee
Kerrie Kensell
DELIVERED ON: 20 December 2012
DELIVERED AT: Brisbane
ORDERS MADE:

1. Pursuant to section 196(1) of the Health Practitioner Regulation National Law Act 2009 (“National Law”), the Tribunal finds that the Registrant has behaved in a way that constitutes professional misconduct.

2. Pursuant to section 196(2)(d) of the National Law, the Registrant’s registration be suspended for a period of six months. The suspension is to commence 7 days from the date of this decision.

3.    The above suspension is to be suspended after the Registrant has served 1 month for an operational period of 12 months during which time the Registrant must not be the subject of any disciplinary action by the Board or the Tribunal.

4. Pursuant to section 196(2)(b) of the National Law, the following conditions be imposed on the Registrant’s registration following the period of suspension:

(a)   The Registrant is to undergo a period of three months supervised practice in an accredited pharmacy for not less than fifty hours per month for three months.

(b)   Upon completion of the period of supervision in condition (a) above, the Registrant is to undergo a period of mentoring for not less than two hours per month for 12 months.

(c)   The mentoring must be face to face and focus on:

(i)    Ethical decision making and dispensing, including the need to counsel clients on a therapeutic use of Schedule 2, 3 and 4 drugs.

(ii)   Strategies to resist pressure to dispense, whether the pressure is exerted by patients, prescribing doctors or employers.

(iii)     The ability to communicate effectively with other health professionals regarding appropriate dispensing of prescriptions.

(d)   For the purposes of conditions (a) and (b) above, the Registrant is to nominate a supervisor/mentor for the approval of the Board, who must be a practising pharmacist and senior to the Registrant in age and experience.

(e)   The mentor must provide a report in writing to the Board at the end of each quarter and at the completion of the mentoring period.

(f)    In addition to completing the mandatory Continuing Professional Development (CPD) requirements set out in the Board’s registration standard for CPD, the Registrant is to complete additional CPD modules in Domain 1 (Professional and Ethical Practice) and Domain 2 (Communication, Collaboration and Self-Management).  The additional modules are to be completed within 12 months.

(g)   The Registrant is to retain membership of the Pharmaceutical Society of Australia for two years.

(h)   The Registrant is only to practice her profession within pharmacies accredited with the Quality Care Pharmacy Program (QCPP) or equivalent for a period of three years.

(i)    The Registrant is to be responsible for paying any costs associated with these conditions.

5.    The…

CaseChat AU logo

Keep reading for free

Create a free CaseChat account to read Pharmacy Board of Australia v Naghdi and more:

  • Read every judgment in full
  • Ask AI and get answers linked to paragraphs
  • See how each paragraph was cited in later cases
  • Download judgments as PDF or Word
Continue with Google

One click creates your free account or signs you in.

By continuing you agree to the Terms and Privacy Policy.

Details
Case
[2012] QCAT 675
Decision Date

CaseChat Overview and Summary

The Pharmacy Board of Australia brought disciplinary proceedings against Ms Sara Naghdi, a pharmacist, for dispensing pseudoephedrine (PSE) in large quantities and at a frequency such that she knew or should have known that the pharmacy was being targeted by drug runners. PSE is a drug prone to abuse and known to be targeted for non-therapeutic purposes, such as in the illegal manufacture of methamphetamines. Ms Naghdi conceded that she had engaged in inappropriate dispensing by not establishing a therapeutic need for the sale of PSE. The Tribunal was required to determine whether Ms Naghdi’s conduct amounted to professional misconduct or unprofessional conduct under the Health Practitioner Regulation National Law Act 2009.

The Tribunal found that Ms Naghdi’s conduct was substantially below the standard reasonably expected of a registered health practitioner of an equivalent level of training or experience. The volume of dispensing in inappropriate circumstances was extreme, and the pharmacy was the highest seller of PSE in Queensland and Australia for the period January 2010 to December 2010. The Tribunal agreed with the expert report from pharmacist Mr Brett Simmonds, who commented that Ms Naghdi’s conduct in dispensing PSE in volumes and frequency that is far in excess of normal pharmaceutical practice, and in dispensing PSE to employees of Queensland Health without determining any therapeutic need or involvement of a pharmacist, and continuing to dispense PSE in significant amounts to customers in circumstances where she knew or ought to have known that the pharmacy was being targeted by drug runners, has breached many of her professional obligations. Ms Naghdi’s conduct is substantially below the standard expected of a reasonable pharmacist. The Tribunal found that she had behaved in a way that constitutes professional misconduct.

The Tribunal considered the proposed sanction of a 6-month suspension suspended after 3 months and a period of supervised practice. Ms Naghdi requested the period of suspension be suspended after 1 month, as her current employer had indicated that if the period of suspension was only 1 month, she could retain her position. The Tribunal found that 6 months supervision suspended after 1 month was appropriate, considering the mitigating factors, such as Ms Naghdi’s lack of previous disciplinary issues and her acknowledgement of her inappropriate dispensing. However, the Tribunal also considered the aggravating factors, such as Ms Naghdi’s knowledge that the pharmacy was being targeted by drug runners and her responsibility for dispensing over 40% of the total PSE during the period 1 January 2008 to July 2010. The Tribunal ordered that Ms Naghdi’s registration be suspended for 6 months, suspended after 1 month, and that she undergo a period of supervised practice, mentoring, and complete additional Continuing Professional Development modules.

The final orders made by the Tribunal included the suspension of Ms Naghdi’s registration for 6 months, suspended after 1 month, and the imposition of conditions on her registration, such as undergoing a period of supervised practice, mentoring, and completing additional Continuing Professional Development modules. The Tribunal also ordered that Ms Naghdi pay the Board’s costs of and incidental to these proceedings in a sum to be agreed or assessed.

Orders

Orders of the court

Background

Background to the litigation

Evidence

Evidence Before The Court

Decision

Reasons for decision

Ratio Decidendi

Legal Principle Established